Risk of a coronary event in patients after ischemic stroke or transient ischemic attack

Ivan Poledník1, Jakub Sulzenko1, Petr Widimsky1

  • 1Department of Cardiology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady; Prague-Czech Republic.

Insights

Coronary artery disease (CAD) is common in stroke survivors, with many unaware of their condition. Early detection and treatment of silent CAD can significantly improve outcomes for these high-risk patients.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Vascular Disease

Background:

  • Coronary artery disease (CAD) and stroke are leading global causes of death, imposing significant health and economic burdens.
  • Ischemic stroke and transient ischemic attack (TIA) survivors exhibit a higher prevalence of coronary atherosclerosis.
  • These patients face an elevated risk of myocardial infarction and non-stroke vascular death.

Purpose of the Study:

  • To investigate the prevalence of coronary atherosclerosis in ischemic stroke survivors and TIA patients.
  • To assess the cardiovascular risk in this patient population.
  • To determine the impact of detecting and treating silent CAD.

Main Methods:

  • A literature search was conducted on PubMed.
  • Studies focused on coronary atherosclerosis in ischemic stroke survivors and TIA patients were reviewed.
  • Cardiovascular risk assessment in these patients was analyzed.

Main Results:

  • Coronary plaques were found in 48%-70% of stroke survivors without a prior CAD diagnosis.
  • Significant stenosis (≥1 coronary artery) was identified in 31% of these patients.
  • CAD is a primary contributor to morbidity and mortality in stroke survivors.

Conclusions:

  • Coronary artery disease is highly prevalent in ischemic stroke and TIA survivors, often asymptomatic.
  • Screening for and managing silent CAD in these individuals is crucial.
  • Intervention may improve long-term prognosis and survival rates.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
271
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
89
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.3K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
116
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
115
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
141